Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 27, Issue 7, Pages 2713-2722
Publisher
FASEB
Online
2013-04-09
DOI
10.1096/fj.12-222992
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of LPS binding to MD-2 co-receptor for suppressing TLR4-mediated expression of inflammatory cytokine by 1-dehydro-10-gingerdione from dietary ginger
- (2012) Sun Hong Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Early Blockade of TLRs MyD88-Dependent Pathway May Reduce Secondary Spinal Cord Injury in the Rats
- (2012) An-hui Yao et al. Evidence-based Complementary and Alternative Medicine
- Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke
- (2012) Takashi Shichita et al. JOURNAL OF NEUROCHEMISTRY
- The role of the immune system in the generation of neuropathic pain
- (2012) Margarita Calvo et al. LANCET NEUROLOGY
- Streptozotocin-induced diabetic hyperalgesia in rats is associated with upregulation of toll-like receptor 4 expression
- (2012) Jian-e Yan et al. NEUROSCIENCE LETTERS
- Morphine activates neuroinflammation in a manner parallel to endotoxin
- (2012) X. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain
- (2011) Peter M. Grace et al. BRAIN BEHAVIOR AND IMMUNITY
- Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation
- (2011) Wei Bi et al. BRAIN RESEARCH
- Toll-like receptors in chronic pain
- (2011) Lauren Nicotra et al. EXPERIMENTAL NEUROLOGY
- Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies
- (2011) Amisha Barochia et al. Expert Opinion on Drug Metabolism & Toxicology
- Nonprofit disease groups earmark grants for drug repositioning
- (2011) Elie Dolgin NATURE MEDICINE
- Signatures for drug repositioning
- (2011) Charlotte Harrison NATURE REVIEWS GENETICS
- Exploring the Neuroimmunopharmacology of Opioids: An Integrative Review of Mechanisms of Central Immune Signaling and Their Implications for Opioid Analgesia
- (2011) M. R. Hutchinson et al. PHARMACOLOGICAL REVIEWS
- Myeloid differentiation 2 as a therapeutic target of inflammatory disorders
- (2011) Sun Hong Park et al. PHARMACOLOGY & THERAPEUTICS
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
- (2010) R. Nau et al. CLINICAL MICROBIOLOGY REVIEWS
- A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
- (2010) Todd W. Rice et al. CRITICAL CARE MEDICINE
- Pregnane X Receptor PXR Activates theGADD45β Gene, Eliciting the p38 MAPK Signal and Cell Migration
- (2010) Susumu Kodama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation
- (2010) J. Cheng et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Rifampicin Inhibits the LPS-induced Expression of Toll-like Receptor 2 via the Suppression of NF-κB DNA-binding Activity in RAW 264.7 Cells
- (2010) Seong Keun Kim et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Changing Face of Microglia
- (2010) M. B. Graeber SCIENCE
- Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2
- (2009) Koji Kuronuma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)
- (2008) Mark R. Hutchinson et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Taxanes inhibit human TLR4 signaling by binding to MD-2
- (2008) Nuša Resman et al. FEBS LETTERS
- Glial TLR4 receptor as new target to treat neuropathic pain: Efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice
- (2008) Isabella Bettoni et al. GLIA
- Paclitaxel Binding to Human and Murine MD-2
- (2008) Shanta M. Zimmer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pathological and protective roles of glia in chronic pain
- (2008) Erin D. Milligan et al. NATURE REVIEWS NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More